A 24-week, randomized, controlled trial of rivastigmine patch 13.3 mg/24 h versus 4.6 mg/24 h in severe Alzheimer's dementia

Files in this item

The following license files are associated with this item:

This item appears in the following Collection(s)

Attribution-NonCommercial 3.0 United States Except where otherwise noted, this item's license is described as Attribution-NonCommercial 3.0 United States

Search Repository


My Account

Statistics